Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Calfactant"'
Autor:
Ga Won Jeon
Publikováno v:
Korean Journal of Pediatrics, Vol 62, Iss 5, Pp 155-161 (2019)
Following the first successful trial of surfactant replacement therapy for preterm infants with respiratory distress syndrome (RDS) by Fujiwara in 1980, several animal-derived natural surfactants and synthetic surfactants have been developed. Synthet
Externí odkaz:
https://doaj.org/article/9cf5469828be417a95257e38262bcd3f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Reese H. Clark, Robert M. Treadway, Kanecia O. Zimmerman, Stephen J. Balevic, Rachel G. Greenberg, Sujata Kishnani, Samuel Eshun Danquah, Aaliyah Langman, Obianuju Udemadu, Wesley M. Jackson, Christoph P. Hornik, Morgan D. Lane, Matthew M. Laughon
Publikováno v:
Journal of Perinatology
OBJECTIVE Characterize the use, efficacy, and safety of poractant alfa and calfactant surfactants compared to beractant in preterm infants receiving late surfactant. STUDY DESIGN We included infants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b2a8aa13acf7f365bf120601ee7d89
http://europepmc.org/articles/PMC8290378
http://europepmc.org/articles/PMC8290378
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 24:117-127
OBJECTIVE To compare length of stay (LOS), costs, mechanical ventilation (MV), and mortality in preterm infants treated in the Neonatal Intensive Care Unit (NICU) with beractant (BE), calfactant (CA), and poractant alfa (PA) for Respiratory Distress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c07d6b49408066c72ca01cd43181a72
https://doi.org/10.5863/1551-6776-24.2.117
https://doi.org/10.5863/1551-6776-24.2.117
Autor:
Kirsten Glaser, Clyde J. Wright
Publikováno v:
Pediatrics
The burden of preterm birth remains substantial, with immature infants surviving at rates higher than ever before but with significant morbidities.1 Bronchopulmonary dysplasia is a leading cause of mortality and long-term impairments.2 Given the dire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a933a36588d9e9904b383ef81cc47e0
https://doi.org/10.1542/peds.2020-021576
https://doi.org/10.1542/peds.2020-021576
Autor:
Aero Study Investigators, Jaime Flores-Torres, George Albert, Devon Kuehn, Anup Katheria, Scott O Guthrie, E Gerday, Stephen D. Minton, Prem Fort, Jonathan R. Swanson, Elie G. Abu Jawdeh, Rita M. Ryan, Praveen Kumar, Gregory C. Martin, Neil Mulrooney, Jörn-Hendrik Weitkamp, Edmund A. Egan, James J. Cummings, Greg Wilding, Mobolaji Famuyide, Dale R. Gerstmann, Andrea Lampland, Fabien G. Eyal
Publikováno v:
Pediatrics. 146
BACKGROUND:Exogenous surfactants to treat respiratory distress syndrome (RDS) are approved for tracheal instillation only; this requires intubation, often followed by positive pressure ventilation to promote distribution. Aerosol delivery offers a sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66950a8bd8589dc60ba80fa775730641
https://doi.org/10.1542/peds.2019-3967
https://doi.org/10.1542/peds.2019-3967
Autor:
Minji Heo, Ga Won Jeon
Publikováno v:
The Turkish journal of pediatrics. 62(4)
Background and objectives Respiratory distress syndrome (RDS) is a major cause of early postnatal death in preterm infants. Bronchopulmonary dysplasia (BPD) is one of the most fatal chronic respiratory complications of preterm infants after managemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df955f36a4ea4a1591b788839c079ca6
https://pubmed.ncbi.nlm.nih.gov/32779407
https://pubmed.ncbi.nlm.nih.gov/32779407
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 23:146-151
OBJECTIVE To compare the pharmacy costs of calfactant (Infasurf, ONY, Inc.) and poractant alfa (Curosurf, Chiesi USA, Inc., Cary, NC). METHODS The University of South Alabama Children's and Women's Hospital switched from calfactant to poractant alfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4f6e021fe1106f5cf18e3d6ac18b25
https://doi.org/10.5863/1551-6776-23.2.146
https://doi.org/10.5863/1551-6776-23.2.146
Autor:
Kirsten Glaser, Clyde J. Wright
Publikováno v:
Acta Paediatrica. 110:1699-1700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a338101feaab2dffd6ed831c9cff2a6f
https://doi.org/10.1111/apa.15807
https://doi.org/10.1111/apa.15807